Evelyn Jager
Mannheim, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
A randomized controlled clinical trial of intranasal versus subcutaneous midazolam for agitation in terminal illness (MinTU study).
Journal: Palliative medicine
Published: March 23, 2026
Evaluation of Hypoxia Markers in Critically Ill Patients Categorized by Their Burden of Organ Dysfunction: A Novel Approach to Detect Pathophysiological and Clinical Relevance in a Secondary Analysis of a Prospective Observational Study.
Journal: International journal of molecular sciences
Published: October 06, 2024
Mortality Prediction by Kinetic Parameters of Lactate and S-Adenosylhomocysteine in a Cohort of Critically Ill Patients.
Journal: International journal of molecular sciences
Published: April 29, 2024
Treatment of agitation in terminally ill patients with intranasal midazolam versus subcutaneous midazolam: study protocol for a randomised controlled open-label monocentric trial (MinTU Study).
Journal: BMC palliative care
Published: October 25, 2023
S-Adenosylhomocysteine Is a Useful Metabolic Factor in the Early Prediction of Septic Disease Progression and Death in Critically Ill Patients: A Prospective Cohort Study.
Journal: International journal of molecular sciences
Published: July 14, 2023
The Use of an Inspiration-Synchronized Vibrating Mesh Nebulizer for Prolonged Inhalative Iloprost Administration in Mechanically Ventilated Patients-An In Vitro Model.
Journal: Pharmaceutics
Published: July 07, 2023
Inhibition of lysyl oxidases synergizes with 5-azacytidine to restore erythropoiesis in myelodysplastic and myeloid malignancies.
Journal: Nature communications
Published: July 15, 2022
Pre-analytical processing of plasma and serum samples for combined proteome and metabolome analysis.
Pre-analytical processing of plasma and serum samples for combined proteome and metabolome analysis.
Journal: Frontiers in molecular biosciences
Published: June 09, 2022
IL4I1 Is a Metabolic Immune Checkpoint that Activates the AHR and Promotes Tumor Progression.
Journal: Cell
Published: December 16, 2019
Intraperitoneal use of doxorubicin drug-eluting beads in sheep: a pilot safety study.
Journal: Anticancer research
Published: December 11, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026